These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 1412875)
1. Triple-drug regimen for first kidney transplants in developing countries. Erken U; Erken E; Tansuğ Z; Türkyilmaz R Transplant Proc; 1992 Oct; 24(5):1843. PubMed ID: 1412875 [No Abstract] [Full Text] [Related]
2. Immunosuppressive protocols at transplantation centers in Turkey. Haberal M; Demirağ A; Bilgin N; Arslan G; Büyükpamukçu N Transplant Proc; 1995 Oct; 27(5):2776-7. PubMed ID: 7482911 [No Abstract] [Full Text] [Related]
3. CyA monotherapy in patients over 50 years of age after renal transplantation: short-term results. Morales JM; Sancho S; Muñoz Cepeda MA; Andres A; Campo C; Alcazar JM; Rodicio JL Transplant Proc; 1992 Feb; 24(1):37-8. PubMed ID: 1539322 [No Abstract] [Full Text] [Related]
4. Prospective randomized study of triple vs conventional immunosuppression in living donor kidney transplantation. Ghoneim MA; Sobh MA; Shokeir AA; Bakr MA; el-Sherif A; Foda MA Transplant Proc; 1993 Jun; 25(3):2243-5. PubMed ID: 8516887 [No Abstract] [Full Text] [Related]
5. Reduction of immunosuppressive therapy after renal transplantation: a randomized study. Heering P; Westhoff A; Ivens K; Kutkuhn B; Grabensee B Transplant Proc; 1994 Oct; 26(5):2530-2. PubMed ID: 7940778 [No Abstract] [Full Text] [Related]
6. Effects of three immunosuppressive drug protocols on cadaver renal transplantation costs after 4 years of therapy. Canafax DM; Carleton BC; Matas AJ; Payne WD; Dunn DL; Sutherland DE; Najarian JS Transplant Proc; 1993 Feb; 25(1 Pt 2):1692-3. PubMed ID: 8442239 [No Abstract] [Full Text] [Related]
7. Renal allograft rejection in a patient with the Wiskott-Aldrich syndrome. Meisels IS; Strom TB; Roy-Chaudhury P; Abrams J; Shapiro ME Transplantation; 1995 Apr; 59(8):1214-5. PubMed ID: 7732568 [No Abstract] [Full Text] [Related]
8. Sri Lankan experience with three immunosuppressive protocols in living related donor kidney transplantation. Sheriffdeen AH; de Abrew K; Jayasekera G; Nanayakkara S; de Mel CP; Jayasinghe S; Fernando H; Rajakanthan K; Weerasinghe A; Kuruppruarchchi L Transplant Proc; 1992 Oct; 24(5):1818. PubMed ID: 1412862 [No Abstract] [Full Text] [Related]
9. Double-therapy vs triple-therapy immunosuppression in cadaveric renal transplants. Carmellini M; Romagnoli J; Pietrabissa A; Di Stefano R; Oleggini M; Rindi P; Rizzo G; Mosca F Transplant Proc; 1994 Oct; 26(5):2546-7. PubMed ID: 7940785 [No Abstract] [Full Text] [Related]
10. Triple-drug immunosuppression significantly reduces chronic rejection in noninfected and RCMV-infected rats. Lemström K; Bruning J; Koskinen P; Bruggeman C; Lautenschlager I; Häyry P Transplant Proc; 1994 Jun; 26(3):1727-8. PubMed ID: 8030105 [No Abstract] [Full Text] [Related]
11. Is HLA matching worthwhile in pancreatic transplantation? Hopt UT; Büsing M; Schareck W; Pfeffer F; Irkin I; Becker HD Transplant Proc; 1992 Jun; 24(3):909-10. PubMed ID: 1604664 [No Abstract] [Full Text] [Related]
12. Triple and quadruple therapy after renal transplantation in patients from developing countries. Slapak M; Shell T; Digard N; Gosling DC; Qerchi della Rovera G; Crockett RC; Ahmed K Transplant Proc; 1987 Feb; 19(1 Pt 3):1922-5. PubMed ID: 3547896 [No Abstract] [Full Text] [Related]
13. Fractional excretion of sodium during pulses of methylprednisolone for treatment of acute rejection in heart and kidney transplants. Lloveras JJ; Tran Van T; Magues JP; Bernadet P; Durand D; Suc JM Transplant Proc; 1990 Aug; 22(4):1384-5. PubMed ID: 2389337 [No Abstract] [Full Text] [Related]
14. Live donor renal transplantation with low-dose triple immunosuppression. Francis DM; Millar RJ; Walker RG; Nicholls K; Powell H; Jones C; Kockelbergh R; Becker G Transplant Proc; 1992 Oct; 24(5):2243. PubMed ID: 1413041 [No Abstract] [Full Text] [Related]
15. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience. Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007 [TBL] [Abstract][Full Text] [Related]
16. Triple drug maintenance therapy in renal transplantation. Pallardó LM; Sánchez J; Hernandez M; Górriz JL; Sánchez P; Beneyto I; Rochera A Transplant Proc; 1992 Feb; 24(1):58-9. PubMed ID: 1539343 [No Abstract] [Full Text] [Related]
17. Late acute rejection in renal transplant recipients: response to steroid treatment. Prieto C; Pulido F; Rodríguez-Paternina E; Algranati C; Bello I; Farias J; G-Millet V Transplant Proc; 1992 Feb; 24(1):35-6. PubMed ID: 1539312 [No Abstract] [Full Text] [Related]
18. OKT3 first-line treatment of acute rejection episodes following combined pancreas and kidney transplantation. Cantarovich D; Hourmant M; Dantal J; Giral M; Paineau J; Karam G; Soulillou JP Transplant Proc; 1994 Apr; 26(2):549. PubMed ID: 8171548 [No Abstract] [Full Text] [Related]
19. Different trends in immunosuppression: 10 years' experience with cyclosporine after living related donor renal transplantation. Bakr MA; Sally S; Foda MA; Sobh MA; el-Sherif AK; Ghoneim MA Transplant Proc; 1994 Dec; 26(6):3163-6. PubMed ID: 7998104 [No Abstract] [Full Text] [Related]
20. OKT3 for steroid-resistant renal allograft rejection: differential response in adults and children. Shmueli D; Nakache R; Lustig S; Bar Nathan N; Yussim A; Shaharabani E; Geier A; Shapira Z Transplant Proc; 1994 Aug; 26(4):1948-9. PubMed ID: 8066630 [No Abstract] [Full Text] [Related] [Next] [New Search]